Back
Vir Biotechnology Vs. Vertex Pharmaceuticals Industry Stock Comparison
Sell
43
VIR
Vir Biotechnology
Last Price:
9.72
Seasonality Move:
13.28%
Buy
71
VRTX
Vertex Pharmaceuticals
Last Price:
445.29
Seasonality Move:
7.52%
Sell
43
Vir Biotechnology (VIR)
is a Sell
Is Vir Biotechnology a Buy, Sell or Hold?
- The current Vir Biotechnology [VIR] share price is $9.73. The Score for VIR is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- VIR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
71
Vertex Pharmaceuticals (VRTX)
is a Buy
Is Vertex Pharmaceuticals a Buy, Sell or Hold?
- The current Vertex Pharmaceuticals [VRTX] share price is $445.21. The Score for VRTX is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- VRTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
VIR Stock Price Chart
What is Vir Biotechnology's stock price today?
-
The Vir Biotechnology share price today is $9.73
The current trend is moderately bullish and VIR is experiencing slight selling pressure.
VRTX Stock Price Chart
What is Vertex Pharmaceuticals's stock price today?
-
The Vertex Pharmaceuticals share price today is $445.21
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
VIR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.21 | Buy |
Relative Strength Index (14 RSI): | 54.77 | Buy |
Chaikin Money Flow: | -308113 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.13 - 9.85) | Buy |
Bollinger Bands (100): | (8.91 - 10.71) | Sell |
VRTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.17 | Buy |
Relative Strength Index (14 RSI): | 79.02 | Buy |
Chaikin Money Flow: | 929485 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (392.72 - 424.92) | Buy |
Bollinger Bands (100): | (403.76 - 430.1) | Buy |
VIR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.76 | Sell |
20-day SMA: | 9.18 | Buy |
50-day SMA: | 9.52 | Buy |
200-day SMA: | 9.97 | Sell |
8-day EMA: | 9.76 | Sell |
20-day EMA: | 9.47 | Buy |
50-day EMA: | 9.49 | Buy |
200-day EMA: | 11.71 | Sell |
VRTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 430.31 | Buy |
20-day SMA: | 412.4 | Buy |
50-day SMA: | 409.66 | Buy |
200-day SMA: | 388.13 | Buy |
8-day EMA: | 430.92 | Buy |
20-day EMA: | 418.59 | Buy |
50-day EMA: | 412.7 | Buy |
200-day EMA: | 390.21 | Buy |
Vir Biotechnology Earnings Growth & VIR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.21 per share, an increase next quarter of $0.10 per share, an increase this year of $1.30 per share, and a decrease next year of $0.48 per share.
Vertex Pharmaceuticals Earnings Growth & VRTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.12 per share, an increase next quarter of $0.78 per share, an increase this year of $2.05 per share, and an increase next year of $1.12 per share.
Vir Biotechnology Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Vertex Pharmaceuticals Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |